1. Immunology and Inflammation
  2. Microbiology and Infectious Disease
Download icon

Neuropathy: Looking into nerve damage in the cornea

  1. Mihaela Gadjeva  Is a corresponding author
  1. Brigham and Women’s Hospital, United States
  2. Harvard Medical School, United States
Insight
  • Cited 0
  • Views 874
  • Annotations
Cite this article as: eLife 2019;8:e51497 doi: 10.7554/eLife.51497

Abstract

Interactions between T helper cells and the complement system promote loss of sensory neurons in the eye.

Main text

The cornea is likely the most densely innervated part of the human body with approximately 7,000 sensory neurons per square millimeter, making it 300 to 600 times more sensitive to stimuli than the skin (Siran et al., 2018; Cruzat et al., 2017; González-González et al., 2017). The majority of neurons in the cornea are nociceptors: they respond to noxious stimuli, such as touch, temperature, and toxins, by signaling pain.

Infections and other inflammatory conditions, such as graft versus host disease (where the host immune system attacks transplanted tissue), are often associated with neuropathies. For example, mice with a herpes simplex virus type 1 (HSV-1) infection in the eye stop perceiving mechanical stimuli due to nerve loss. However, the molecular mechanisms that govern neuropathy are still unknown. Understanding which molecules initiate the process could lead to new therapies for targeted pain management.

Infectious and non-infectious responses to inflammation often activate the complement system – an evolutionarily conserved system with over 30 soluble and membrane-associated proteins that enhance the ability of the immune system to clear infection. The complement system is usually activated by antibodies bound to the surfaces of pathogens such as viruses, bacteria or fungi, and it self-assembles through a well-coordinated cascade of proteolytic events. Every activation of the complement system eventually leads to the proteolytic cleavage of a protein called C3. Once cleaved, C3 undergoes a conformational change, exposing an active site that allows it to covalently bind to target surfaces. Labeling of a pathogen by C3 is a unique event that tags the target for clearance (Gadjeva et al., 1998).

The activation of the complement system occurs within seconds of a pathogen being recognized, and while its main purpose is to control pathogen spread, additional activities have been discovered. Now, in eLife, Derek Royer and colleagues at Duke University Medical School and the University of Oklahoma Health Sciences Center report on the effects of complement activation on the nerves in the cornea (Royer et al., 2019).

Royer et al. first showed that, in contrast with wild type mice, mice deficient for C3 did not lose mechanosensation in the cornea when infected with HSV-1. Consistent with this, these mice did not suffer nerve loss. These data illustrate that C3-dependent inflammatory processes lead to neuronal loss.

Next, Royer et al. showed that mice lacking T cells (a type of immune cell) did not lose sensation in the cornea when they were infected with HSV-1, despite having wild-type C3 protein. T helper cells are a type of T cell that produces proteins called cytokines to recruit other immune cells to the site of infection. When T helper cells were transferred from wild-type or C3 mutant mice infected with HSV-1 into mice without T cells, these mice progressively lost nerve endings in the cornea. This demonstrates that nerve and sensation loss in the cornea associated with HSV-1 infection require T helper cells.

Collectively, these data show that coordinated C3-dependent and T helper cell-dependent pathways are responsible for the loss of sensation in mice infected with HSV-1, although the exact mechanisms remain to be described.

Royer et al. also found that using drugs to prevent activation of the complement system reduced nerve damage upon HSV-1 infection, suggesting that the complement cascade could be a target in efforts to control neuronal integrity. Importantly, similar pathways are operational in a mouse model of graft versus host disease, where inhibiting the activation of complement rescued perception of mechanical cues and reduced neuronal loss. Finally, Royer et al. established that the C3 that caused tissue damage in the cornea was made by local myeloid and non-hemaotopoietic cells upon acute HSV-1 infection.

Together, these findings provide a strong foundation for future experiments to determine the possible molecular mechanisms linking the activation of the complement system and neuropathy (Figure 1). One hypothesis is that T helper cells in the cornea produce a cytokine called interferon: this causes myeloid cells to produce C3, resulting in neuron damage downstream. Another possibility is that products of complement cleavage stimulate macrophages to release neuronal growth factors, inducing overactivation of the Transient Receptor Potential Cation Channel Subfamily V Member 1 (TRPV1) in nociceptors, which leads to nerve damage (Shutov et al., 2016; Danigo et al., 2014). Alternatively, the complement system may induce assembly of the membrane attack complex on host cells. This complex usually attacks bacteria, but it might also damage the membranes of neurons.

Complement activation triggers neuronal damage.

The classical pathway or the lectin pathway can both activate the complement system (left) resulting in a proteolytic split of C3, which releases C3a and C3b. C3b (not shown) becomes a part of an enzyme known as the C5 convertase, which cleaves another complement protein called C5, releasing C5a and C5b. C5b (not shown) participates in the assembly of the membrane attack complex (MAC), which can lead to nerve damage when it forms on neuronal membranes (right). Complement cleavage products C3a and C5a can bind to the C3a receptor (C3aR) and the C5a receptor (C5aR) on myeloid cells called macrophages (top center), potentially inducing the synthesis of neuronal growth factors (NGF). NGF production could cause nerve damage through the overactivation of TRPV1 on sensory neurons. T helper cells (CD4 T cells, top left) coordinate with C3 to damage nerve cells upon HSV-1 infection. This coordination may happen through T helper cells producing interferon, which then induces myeloid cells (top center) to synthesize local complement proteins.

Today, there are more than 20 candidate drugs that block different aspects of complement activation. Understanding at which level the complement cascade has to be blocked to reduce the onset of nerve damage will ensure that existing therapies are applied more effectively, allowing faster translation to patients.

References

    1. Gadjeva M
    2. Dodds AW
    3. Taniguchi-Sidle A
    4. Willis AC
    5. Isenman DE
    6. Law SK
    (1998)
    The covalent binding reaction of complement component C3
    Journal of Immunology 161:985–990.

Article and author information

Author details

  1. Mihaela Gadjeva

    Mihaela Gadjeva is in the Division of Infectious Disease, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States

    For correspondence
    mgadjeva@rics.bwh.harvard.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9014-386X

Publication history

  1. Version of Record published: October 8, 2019 (version 1)

Copyright

© 2019, Gadjeva

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 874
    Page views
  • 53
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cell Biology
    2. Immunology and Inflammation
    Bochuan Li et al.
    Research Article Updated

    Atherosclerosis preferentially occurs in atheroprone vasculature where human umbilical vein endothelial cells are exposed to disturbed flow. Disturbed flow is associated with vascular inflammation and focal distribution. Recent studies have revealed the involvement of epigenetic regulation in atherosclerosis progression. N6-methyladenosine (m6A) is the most prevalent internal modification of eukaryotic mRNA, but its function in endothelial atherogenic progression remains unclear. Here, we show that m6A mediates the epidermal growth factor receptor (EGFR) signaling pathway during EC activation to regulate the atherosclerotic process. Oscillatory stress (OS) reduced the expression of methyltransferase like 3 (METTL3), the primary m6A methyltransferase. Through m6A sequencing and functional studies, we determined that m6A mediates the mRNA decay of the vascular pathophysiology gene EGFR which leads to EC dysfunction. m6A modification of the EGFR 3’ untranslated regions (3’UTR) accelerated its mRNA degradation. Double mutation of the EGFR 3’UTR abolished METTL3-induced luciferase activity. Adenovirus-mediated METTL3 overexpression significantly reduced EGFR activation and endothelial dysfunction in the presence of OS. Furthermore, thrombospondin-1 (TSP-1), an EGFR ligand, was specifically expressed in atheroprone regions without being affected by METTL3. Inhibition of the TSP-1/EGFR axis by using shRNA and AG1478 significantly ameliorated atherogenesis. Overall, our study revealed that METTL3 alleviates endothelial atherogenic progression through m6A-dependent stabilization of EGFR mRNA, highlighting the important role of RNA transcriptomics in atherosclerosis regulation.

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    George Elias et al.
    Research Article

    Antigen recognition through the T cell receptor (TCR) αβ heterodimer is one of the primary determinants of the adaptive immune response. Vaccines activate naïve T cells with high specificity to expand and differentiate into memory T cells. However, antigen-specific memory CD4 T cells exist in unexposed antigen-naïve hosts. In this study, we use high-throughput sequencing of memory CD4 TCRβ repertoire and machine learning to show that individuals with preexisting vaccine-reactive memory CD4 T cell clonotypes elicited earlier and higher antibody titers and mounted a more robust CD4 T cell response to hepatitis B vaccine. In addition, integration of TCRβ sequence patterns into a hepatitis B epitope-specific annotation model can predict which individuals will have an early and more vigorous vaccine-elicited immunity. Thus, the presence of preexisting memory T cell clonotypes has a significant impact on immunity and can be used to predict immune responses to vaccination.